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doi:10.1016/j.jtcvs.2007.07.052bjective: In critical left ventricular outflow tract obstruction, the common percep-
ion that biventricular physiology is superior to univentricular physiology has led to
bias favoring biventricular repair. We hypothesized that pursuit of biventricular
epair in borderline candidates increases mortality.
ethods: Between 1994 and 2001, 362 neonates with critical left ventricular
utflow tract obstruction were prospectively enrolled by 26 institutions. Initial
rocedure indicated intended univentricular repair (n  223; 84 deaths) or biven-
ricular repair (n  139; 39 deaths). Parametric risk–hazard analysis identified
redictors of death for univentricular and for biventricular repair, which allowed
rediction of the 5-year univentricular survival advantage for every infant. Survival
as scrutinized for children managed discordantly to univentricular survival advan-
age predictions.
esults: Incremental factors for death after univentricular repair were as follows:
ricuspid regurgitation, smaller mitral annulus z-score, smaller indexed dominant
entricular length, and presence of a large ventricular septal defect; risk factors after
iventricular repair were as follows: minimum left ventricular outflow tract diam-
ter, endocardial fibroelastosis, left ventricular dysfunction, and smaller mid-aortic
rch. These variables formed the univentricular survival advantage tool (all P 
0001, R2  0.92). Discordant management was more common with biventricular
han with univentricular repair (56% vs 21%; P  .01). Discordant pursuit of
iventricular repair was associated with significantly more observed versus expected
eaths (biventricular repair 30 vs 14; P  .001; univentricular repair 20 vs 13; P 
02). Survival after biventricular repair is sensitive to changes in univentricular
urvival advantage values, especially in borderline candidates. In contrast, univen-
ricular repair survival is insensitive to changes in univentricular survival advantage
alues.
onclusions: Inappropriate pursuit of biventricular repair in borderline candidates is
ore frequent and more consequential in survival terms than is inappropriate pursuit
f univentricular repair. Use of the univentricular survival advantage tool will help
dentify infants for whom univentricular repair may be a better choice than attempt-
ng biventricular repair.
n treating the spectrum of critical left ventricular outflow tract (LVOT) obstruc-
tion, making the wrong initial choice between biventricular (BVR) versus
univentricular repair (UVR) can prove fatal. The common perception that
iventricular physiology is inherently superior to univentricular physiology has led
o a bias favoring BVR.1 We hypothesized that pursuit of BVR in border
andidates increases mortality.
The Congenital Heart Surgeons’ Society (CHSS) has previously published a
rediction model to aid in optimal decision-making for neonates with critical LVOT
bstruction.1 We subsequently discovered that the decision logic was overly sensi-
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Dive to age at admission. In addition, the increasing occur-
ence of antenatal diagnosis complicates the determination
f precise age at admission. Therefore, we have refined the
odel by expanding the cohort, extending follow-up dura-
ion, and using more robust analytic methods. Using the
ew model, we categorized actual management strategies as
oncordant or discordant with respect to the model’s pre-
iction for optimal survival. The survival impact of discor-
ant decisions was evaluated.
atients and Methods
etween 1994 and 2001, an inception cohort of 410 consecutive
eonates with a diagnosis of critical LVOT obstruction was pro-
pectively recruited by 26 CHSS institutions. Choice of treatment
trategy was at the discretion of the treating physicians. Participa-
ion in this project and submission of patient information were
oluntary and confidential. Both parental consent for enrollment
nd ethics board approval were obtained by individual institutions
nd the CHSS Data Center.
Critical neonatal LVOT obstruction was defined as stenosis
ccurring at any level from the subvalvular region to the innom-
nate artery with or without left ventricular hypoplasia, such that
he systemic circulation was ductus dependent. Of the 410 neo-
ates, 366 met inclusion criteria of atrioventricular and ventricu-
oarterial concordant connections, aortic and mitral valve patency,
nd aortic arch continuity and underwent an intervention to relieve
bstruction within 30 days of birth. We excluded 4 patients re-
erred for cardiac transplantation from subsequent analysis, leav-
ng a study cohort of 362 neonates (Figure E1).
Patient data were accrued and managed as previously de-
cribed.1 Echocardiograms (n  214 patients) were requested an
eviewed by a blinded examiner. If echocardiograms were not
vailable, functional and morphologic indices (Table E1) w
xtracted from reports. Patients’ families were contacted annually
y the CHSS Data Center staff, and completeness of this follow-up
as 88% in 2006.
rocedures
ntent to treat was determined by the index intervention directed
oward the LVOT. UVR was pursued in 223 neonates (62% of the
ohort) with stage I Norwood palliation (Figure E2). Of the
nderwent transplantation, and 1 was converted to BVR. All are
ncluded in the UVR analysis.
BVR was pursued in 139 neonates (38% of the cohort). Index
Abbreviations and Acronyms
BAV  balloon aortic valvotomy
BVR  biventricular repair
CHSS  Congenital Heart Surgeons’ Society
EFE  endocardial fibroelastosis
LVOT  left ventricular outflow tract
UVR  univentricular repair
UVR-SA univentricular repair survival advantage
VSD  ventricular septal defectntervention was balloon aortic valvotomy (BAV) (n  105), 5
430 The Journal of Thoracic and Cardiovascular Surgery ● Decurgical aortic valvuloplasty (n  34), autograft aortic valve re-
lacement (Ross–Konno procedure,2 n  5), and Yasui proce-
ure3,4 (n  2) (Figures E3 and E4). Of these, 1 under
ransplantation and 11 were converted to UVR. All are included in
he BVR analysis.
nalytic Methods
he analytic objective was to determine the 5-year survival ad-
antage conferred by pursuing UVR versus BVR. We refer to this
alculated UVR survival advantage as the UVR-SA decision tool.
UVR-SA decision tool. Development of the UVR-SA tool
ncluded the following: (1) separate risk factor analyses for death
fter intended UVR and BVR management, (2) prediction of
-year survival for each patient with either strategy using these
nalyses, and (3) identification of predictors for the survival dif-
erence between strategies.
Separate parametric models for time-related survival after in-
ended UVR and BVR were generated as previously describe1,5
owever, covariates representing age or surrogates thereof were
uppressed in the current multivariable analyses (see below). One
ew covariate investigated was minimal LVOT diameter (regard-
ess of level). Variable selection used bagging.6 One thousand
ootstrap samples were analyzed automatically with P .1 for
etention of variables. Those appearing in 50% or more of boot-
trap models or clusters were considered reliable for inclusion in
he final models.
Age at admission and age at first intervention were suppressed
n both UVR and BVR models. We tested this decision by explor-
ng correlation of age with morphologic and functional variables,
ts colinearity with other variables and survival, goodness of fit of
he model with and without age, and its relation to decision
anagement.
Using the UVR and BVR multivariable equations, we esti-
ated 5-year survival for each patient, first as if the patient had
ndergone UVR and second as if the patient had undergone BVR.
ifferences between predictions for UVR 5-year survival and
VR 5-year survival were analyzed by bagging and linear regres-
ion to generate the UVR-SA tool.
Use of UVR-SA tool to classify discordant management
ecisions. For each patient, the UVR-SA values were calculated
nd used to predict the “optimal management decision” for that
atient.
A positive value favors UVR management and a negative value
avors BVR management. For a given patient, if predicted 5-year
urvival for UVR is 75% and for BVR is 60%, the UVR-SA value
ould be 15, indicating a 15-point survival difference favoring
VR. Alternatively, if predicted survival for UVR is 52% and for
VR is 60%, the UVR-SA value would be 8, indicating an
-point survival difference favoring BVR. A UVR-SA value of
ero indicates that predicted survival is equal with either approach,
nd therefore neither is favored over the other.
When the UVR-SA prediction was in accordance with clinical
ntent to treat, management was labeled as “concordant.” When the
VR-SA prediction was not in accordance with clinical intent to
reat, management was labeled as “discordant.”
Survival consequences of discordant management. Three
ethods were used to compare actual survival with best predicted
-year survival according to the UVR-SA value. For each group
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DUVR concordant, UVR discordant, BVR concordant, BVR dis-
ordant), Kaplan–Meier survival estimates were generated. In ad-
ition, for each patient, cumulative hazard was estimated at the
ime of follow-up by the multivariable equation for the manage-
ent pathway associated with the best predicted 5-year survival.
xpected number of deaths was the sum of these cumulative
azard estimates. This was compared with actual deaths by the 2
est. Finally, for each patient a survival curve was generated by the
ultivariable equation for the management pathway with the best
redicted 5-year survival. Survival curves for infants within each
f the 4 groups were aggregated and the mean was compared with
orresponding Kaplan–Meier estimates.
esults
lements of the UVR-SA Tool
isk factors for death differed by management strategy
UVR vs BVR).
Five-year unadjusted survival after UVR was 62% 3%
Figure E5). Incremental risk factors for death inclu
oderate or severe tricuspid regurgitation (P  .01), large
entricular septal defect (VSD, P  .01), smaller mitral
alve z-score (P  .01), and smaller indexed length of the
ominant (apex-forming) ventricle (P  .02). Moderate or
evere tricuspid regurgitation or a large VSD were associ-
ted with especially poor survival (Figure E6).
Five-year unadjusted survival after BVR was 71% 4%
Figure E5). Incremental risk factors for death inclu
maller minimum indexed LVOT diameter (P  .01), left
entricular dysfunction (P  .02), higher grade of endocar-
ial fibroelastosis (EFE, P  .01), and smaller indexed
id-aortic arch diameter (P  .05). Severe EFE or LVOT
iameters smaller than 4 mm were associated with espe-
ially poor survival after BVR (Figure E7, a).
The regression equation for 5-year survival advantage of
VR over BVR (UVR-SA tool) included the 8 risk factors
or death after BVR or UVR (Table 1; R2  0.92).
nvestigating the Decision to Suppress “Age” Variables
or UVR, older age at intervention was weakly associated
ith higher mortality but younger age was not. In contrast,
or BVR, younger age had a disproportionately strong as-
ociation with higher mortality (Figure 1, a) and discordan
ecision making (Figure 1, b). Very young age at interve
ion in the BVR group was determined by smaller aortic
alve z-score (rather than minimum LVOT diameter at
ther levels) and not other features (for example left ven-
ricular dysfunction). However the smaller aortic valve z-
core was only associated with young age at BVR interven-
ion for those infants discordantly managed (Figure 1, c).
Left ventricular dysfunction and arch hypoplasia were
ound to be colinear with age in the BVR model; thus,
oodness of fit of the model without age (log likelihood 
48.44 and with age in place of these 2 variables (logikelihood  48.45) were nearly identical. Therefore, left n
The Journal of Thoracicentricular dysfunction and arch hypoplasia replaced age as
ovariates within the model, with no loss to overall good-
ess of fit.
se of UVR-SA Tool to Classify Discordant
anagement Decisions
he distribution of UVR-SA values in the 362 study pa-
ients ranged from 78 (strongly favoring UVR) to 81
strongly favoring BVR) with a median of 15. For a
eonate with the mean UVR-SA value of 15, predicted
-year survival is 15% better with UVR than with BVR.
VR-SA value was negative in 30% of patients (favoring
VR) and positive in 70% (favoring UVR).
The median UVR-SA value within the UVR group was
29 (range 81 to 78, Figure 2, dashed line). A positiv
alue (79% of this group) indicated that the actual strategy
ursued was concordant with the predicted strategy of the
VR-SA value (“UVR concordant”). A negative score
21% of this group) indicated that the strategy pursued was
iscordant with the predicted strategy (“UVR discordant”).
The median UVR-SA value within the BVR group was
4 (range 32 to 78, Figure 2, solid line), indicating 
% survival advantage for UVR. The UVR-SA value was
ABLE 1. Incremental risk factors for time-related death
or patients who had an initial procedure indicating an
ntended biventricular repair pathway
ovariate Estimate P value
ntercept .484 .001
resence of moderate or severe tricuspid
regurgitation
.279 .001
-score of mitral valve annulus .030 .001
resence of large VSD .312 .001
ength of apex-forming ventricle (cm)* .715 .001
inimum diameter of the LVOT (cm)† .892 .001
resence of left ventricular dysfunction‡ .230 .001
rade of endocardial fibroelastosis§ .165 .001
iameter of the mid-aortic arch (cm) .187 .001
isk factors in normal font represent those identified as predictors for
eath after univentricular repair and those in italicized font represent those
dentified as predictors for death after biventricular repair. VSD, Ventric-
lar septal defect; LVOT, left ventricular outflow tract. *Echocardiographic
easurement from crux of the heart to the apex, regardless of whether
ormed by the left or right ventricle. Indexed to height of the patient.
Minimum diameter measured at any point from the subvalvular region as
ar distal as the brachiocephalic artery. Indexed to body surface area and
ntered after inverse transformation. ‡Presence of any degree left ven-
ricular dysfunction, including mild. §Endocardial fibroelastosis was graded
ubjectively by the echocardiographic appearance of left ventricular en-
ocardial brightness and thickening as follows: 0 none; 1 involvement
f papillary muscles only; 2  papillary muscle with some endocardial
urface involvement; 3  extensive endocardial surface involvement.
Measured immediately proximal to the left subclavian artery and indexed
o the body surface area.egative in 45% of this group, indicating concordance be-
and Cardiovascular Surgery ● Volume 134, Number 6 1431
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Dween the UVR-SA predictions and the actual strategy pur-
ued (“BVR concordance”). In 55%, however, the UVR-SA
alue was positive, indicating that predicted survival was
etter with UVR, and these infants were labeled “BVR
iscordant.”
urvival Consequences of Discordant Management
ive-year survival with UVR management was similar
ith concordant and discordant management, 63% versus
6%, respectively. If BVR had been pursued for discor-
ant UVR patients, the predicted 5-year survival would
ave been 70% (Figure 3) and 7 deaths may have 
revented (20 actual vs 13 expected with BVR manage-
ent; P  . 02, Table 2).
Five-year survival with concordant BVR management
as 85%, and with discordant BVR management, 60%. If
VR had been pursued for discordant BVR patients, the
redicted 5-year survival would have been 81% (Fig
) and 16 deaths may have been prevented (30 actu
4 expected with UVR management; P  .001, Table 2)
Discordant decisions result in a decrease in survival in
oth UVR and BVR cohorts. However, a discordant BVR
ecision is more expensive in survival terms than a discor-
ant UVR decision. This is because BVR survival is highly
ensitive across the range of UVR-SA values (Figure 5a),
hereas UVR survival is relatively impervious to changes
n UVR-SA values (Figure 5, b).
iscussion
rincipal Findings
UVR-SA tool. Our revised UVR-SA tool is a decision
id that compares predicted survival with UVR and BVR
cross the full spectrum of critical LVOT obstruction. It
ncorporates morphologic, functional, and pathologic infor-
ation to determine the relative risks associated with the
ursuit of one strategy versus the other. For any particular
hild, the relative predominance of risk factors, therefore,
etermines which strategy is associated with the more fa-
orable survival prediction.
Determinants of survival after UVR. Tricuspid regur-
itation is associated with increasing mortality after UVR
nd was also identified in the previous CHSS prediction
odel1 and this revision. It contributes to volume overl
ortic valve z-score and age at intervention (r  0.06). Collectively,
hese findings imply that very early BVR intervention (BAV in 83%
ounger than 3 days) driven by small aortic valve z-scores is fre-
uently a discordant decision with a high incidence of death. The
VR-SA tool will identify patients in whom UVR would offer better
urvival in tight valvular aortic stenosis. BVR, Biventricular repair;
AV, balloon aortic valvotomy; UVR-SA, univentricular repair sur-igure 1. Exploration into the association between age and BVR
anagement. A, The logistic probability of death after intended BVR
ollows an inverse relationship to the age at index intervention.
iscordantly managed patients (solid line) carry a higher risk of
ortality at all ages, but especially so at young ages. Mortality for
oncordantly managed patients (broken line) is only associated with
xtremely young ages (<days). B, The probability of receiving a BVR
iscordant management is strongly associated with young age at
ntervention. C, The aortic valve z-score is the strongest predictor of
ge at intervention, but only in the BVR discordant group (r  0.45).ival advantage.
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Dight ventricular failure, and compromised cardiac output.
ttempts to repair established or new-onset tricuspid regur-
itation are increasingly being made to reduce attrition after
he Norwood palliation and improve the chances of success-
ul Fontan repair.7
Mitral annular size correlates highly with left heart struc-
ural dimensions and also with mortality after UVR, and it
ikely represents a robust surrogate for overall left-sided
tructural hypoplasia. A small annulus did not correlate with
itral stenosis or regurgitation. Although UVR largely neu-
igure 3. Actuarial Kaplan–Meier survival of UVR infants man-
ged discordantly (circles), compared with parametric predicted
urvival for the same patients if they had instead received BVR as
he UVR-SA decision tool advised. Error bars and dashed lines
nclose 70% confidence intervals. Survival differences are sig-
ificant (P  .02). UVR, Univentricular repair; BVR, biventricularsepair; UVR-SA, univentricular repair survival advantage.
The Journal of Thoracicralizes the inadequacy of the left ventricle, others have
emonstrated improved survival after Norwood palliation in
ituations in which the left heart is not hypoplastic.8,9
Larger indexed length of the dominant ventricle was
ssociated with improved survival in UVR. Because the
ominant ventricle was almost exclusively the right ventri-
le, this variable may reflect the functional adequacy of the
ight ventricle in assuming the systemic role. Right-sided
unctional variables were sparse in our UVR-SA model
evelopment and those of others.10,11 The identification o
his unusual variable therefore reinforces the need to more
losely quantify the influence of right ventricular features
n outcome in critical LVOT obstruction.
Although we have found the presence of a large VSD to
e associated with increased mortality after UVR, we can-
ot offer an explanation for this.
Determinants of survival after BVR. Both here and pre-
iously,1,11,12 EFE has been identified as an important predicto
eath after BVR, even when left ventricular function is adequate.
lthough the reliability of diagnosing EFE by echocardiography
as been questioned, we1 have previously demonstrated correla-
ion between preintervention evaluation and findings at autopsy.
urthermore, we and others11 have found that thickened ech
right endocardium is a robust prognostic determinant, regardless
f true correlation with pathologic specimens.
A newly considered variable, the minimum LVOT di-
ension (regardless of level), was a more reliable risk factor
han any single level of LVOT obstruction, including the
ortic valve. A small aortic valve z-score is, however, a
eature associated with early BVR intervention (particularly
AV) and death,1,11,13 especially in very young children1
nclusion of the broader concept of minimum LVOT dimen-
Figure 2. Distribution histogram of UVR-SA values
for the BVR (solid line) and UVR (dashed line)
cohorts. The median value was 29 for the UVR
group (dashed arrow) and 4 for the BVR group
(solid arrow). All of those 176 UVR children (79%)
with a UVR-SA value > 0 had better predicted
survival with UVR and therefore their management
was “concordant” with the UVR-SA predictions.
The 47 UVR children (21%) with a UVR-SA value<
0 had better predicted survival with BVR and there-
fore their management was “discordant.” All of the
63 BVR children (45%) with a UVR-SA value < 0
had better predicted survival with BVR, and there-
fore their management was “concordant” with the
UVR-SA predictions. Those 76 UVR children (55%)
with a UVR-SA value > 0 had better predicted
survival with UVR, and therefore their management
was “discordant.” See Figure 1 for definitions of
abbreviations.ion allows identification of additional neonates with more
and Cardiovascular Surgery ● Volume 134, Number 6 1433
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Diffuse LVOT hypoplasia who also respond poorly to aortic
alvotomy. An indexed LVOT diameter smaller than 16
m/m2 (equivalent to 4 mm for a body surface are
.25 m2) confers disproportionately poor predicted survival
fter BVR (Figure E7, a).
The importance of diffuse LVOT hypoplasia is empha-
ized by the impact of distal arch dimensions on survival
fter BVR. More diffuse phenotypic disease is likely to be
ess amenable to either surgical or balloon valvotomy alone.
n some infants, distal arch hypoplasia and coarctation may
redominate, a condition recently termed hypoplastic left
eart complex.14 This latter circumstance requires interve-
ion directed primarily toward the arch and we therefore
onsider it a separate entity.
Age. Suppression of age in this revision of the UVR-SA
rediction model does not undermine its clinical impor-
ance. Other informative variables have instead been incor-
orated without compromising goodness of fit. Age vari-
bles are problematic, first because of imprecision (age at
dmission) and second because they may be prone to ma-
ipulation (age at intervention). Variables that may be ma-
igure 4. Actuarial time-related survival of biventricular patients
anaged discordantly (circles), compared with parametric con-
inuous point estimates of survival for the same patients if they
ad instead received UVR in accordance with UVR-SA tool pre-
ictions. Error bars and dashed lines enclose 70% confidence
ntervals. Survival differences are significant (P < .001). UVR-SA,
ABLE 2. Comparison of actual and expected deaths betw
No. of patients % Incorrect
VR concordant 177 0
VR concordant 61 0
VR discordant 46 21
VR discordant 78 56
VR, Univentricular repair; BVR, biventricular repair.niventricular repair survival advantage. S
434 The Journal of Thoracic and Cardiovascular Surgery ● Decf
ipulated by the user are inherently undesirable for a pre-
ictive model based on patient-specific characteristics. For
xample, no inference can be made that delaying the date of
the study groups
Expected deaths Actual deaths Predicted vs actual
59 (33%) 64 (36%) .47
8 (13%) 9 (15%) .71
13 (28%) 20 (43%) P  .02
14 (18%) 30 (38%) P  .001
igure 5. Parametric continuous point estimates of predicted
-year survival for (a) BVR or (b) UVR across the spectrum of
VR-SA values. The 95th centiles for UVR-SA values in the CHSS
ritical LVOT obstruction cohort range from 24 to 66. Fine
ashed lines enclose 70% confidence intervals. Survival for BVR
s far more sensitive to changes in UVR-SA values. The steep
lope of the BVR curve (a) corresponds to a sharp fall in survival.eenee Figure 1 for definitions of abbreviations.
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Dntervention will alter outcome, yet the inclusion of age
rovides the potential for this erroneous decision logic. In
ddition, the increasing advent of fetal diagnosis further
onfounds the use of admission age as a variable.15 Because
oung age is an especially strong determinant of poor out-
ome after BVR, small inadvertent variations will result in
arge predictive differences.
Interestingly, young age is a risk factor for BVR16 but
ot for UVR (where it may even be protective.17) We
herefore explored functional and anatomic features for
hich young age at BVR is a surrogate. Only a smaller
ortic valve z-score was identified, and this was only within
hose BVR infants discordantly managed (the majority by
AV). The inference is that tight, discrete aortic valve
tenosis requiring very early intervention is often managed
y BAV, with high resulting mortality. The UVR-SA tool
dentifies 80% of these high-risk infants as being better
erved by UVR. The impact of BVR (especially BAV) in
xtremely young neonates needs to be further explored.
Alternative models for critical LVOT obstruction. Other
rediction models have been devised for critical LVOT
bstruction, including the Rhodes score,10 which has been
ecently tested against the previous CHSS model.11 How-
ver, the Rhodes score was generated in a homogeneous
ubset of infants with discrete valvular stenosis (not neces-
arily ductus-dependent), all of whom had BVR. It is there-
ore applicable only to the most favorable cases, ideally
uited to BAV. Furthermore, it provides no survival com-
arison with an alternative strategy. Colan and associat11
ave nevertheless reported the revalidation of the Rhodes
core, although in a population of infants preselected for
VR on the basis of favorable features.
UVR-SA tool to improve decision management. In the
linical arena, we recognize that the UVR-SA tool should be
een as an aid to decision making, not a rule. The UVR-SA
ool must be applied to an individual patient in the context
f local expertise and family preference. However, larger
VR-SA values should prompt greater caution when pur-
uing discordant management than more modest (border-
ine) values. Furthermore, the sensitivity of BVR survival to
hanges in UVR-SA indicates that discordant pursuit of
VR is more costly in survival terms than discordant pur-
uit of UVR. In fact, infants receiving discordant BVR
isplay the best predicted UVR survival (80% at 5 years).
imitations
everal limitations are inherent in the use of our prediction
odel. Although the tool integrates complex information, it
oes not include all patient characteristics or factors specific
o an individual institution. Also, the UVR-SA tool uses
urvival as the end point, without considering functional
erformance, reintervention, or quality of life, which are all
mportant considerations. This present analysis identified t
The Journal of Thoracicnly early hazard phases. It is likely that late hazard phases
xist for both strategies, particularly after UVR.18 Similarly,
he impact on survival of unplanned reintervention after
VR is not clearly understood.
The use of death as the primary end point has not
ncluded “crossovers” to opposite strategies as “events.”
owever, crossover from BVR to UVR (n  12, 9%) was
onsiderably more frequent than the converse (n  7, 3%).
herefore, an analytical strategy incorporating crossovers as
vents further biases against BVR in borderline cases and
ould strengthen our message further.
As practice evolves with the more widespread use of
odalities such as the Ross–Konno procedure, hybrid pal-
iation,19 and modifications of the Yasui procedure,4 the
VR-SA will require recalibration with new cohorts and
ontinued follow-up. The CHSS is presently enrolling a
ontemporary cohort for the purposes of model revalidation
nd refinement while exploring modern treatment modali-
ies and investigating functional outcomes.
The advantage of studying a multi-institutional cohort is
hat the full spectrum of management strategies (and out-
omes) is incorporated. However, a disadvantage is that
nstitution-specific factors may influence the development
nd application of a predictive model. For example, insti-
ution-specific differences in outcome may have biased the
isk factors associated with one strategy or the other. Sim-
larly, the applicability of the model’s predictions may be
eopardized by differences in local technical expertise.
Finally, this analysis has been undertaken on a cohort
etween 1994 and 2001. Although outcomes of all proce-
ures are likely to have improved since then, we would
ontend that outcomes after UVR have enjoyed a more
ronounced relative improvement. For example, several
roups are reporting operative mortality below 20%20 and
ven approaching 10%21,22 after stage I Norwood palliatio
elatively greater improvements in UVR survival would
urther strengthen our conclusions.
Implicit in the use of prediction models is that heeding
heir advice will translate into improved clinical outcomes.
he ideal revalidation of our model would involve a pro-
pective trial in which infants managed in accordance with
he UVR-SA tool are compared with infants managed ac-
ording to current clinical practice. Such a trial seems
nlikely. However, a cohort of neonates with LVOT ob-
truction that the CHSS is presently enrolling will serve as
n ideal substrate for comparing the overall predictive ac-
uracy of survival.
onclusions
he UVR-SA tool identifies morphologic and functional
ndicators of poor outcome before intended UVR or BVR.
he greater the magnitude of the UVR-SA value, the greaterhe potential survival cost when pursuing a discordant strat-
and Cardiovascular Surgery ● Volume 134, Number 6 1435
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CH
Dgy. Discordant pursuit of BVR in borderline candidates is
ore frequent than the discordant pursuit of UVR, likely
riven by an intuitive notion that “two ventricles are better
han one.” Discordant BVR is more costly in survival terms
han discordant UVR. Use of the UVR-SA value will iden-
ify infants for whom UVR may be better than attempting
VR in the face of challenging morphologic, functional,
nd pathologic features. The UVR-SA is freely available on
he CHSS Web site (www.chss.org).
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iscussion
r Edward L. Bove (Ann Arbor, Mich). I would like to thank Dr
ickey and his coauthors from the CHSS for an excellent study
ith a new, at least to me, statistical evaluation tool. In this
resentation, the authors have asked the age-old question: “Is a
igh-risk BVR better than a low-risk UVR approach?” Despite the
ubstantial decline in early mortality for univentricular approaches,
ost centers still desire to push borderline patients to a BVR,
elieving that it is safer and affords better long-term outcome. The
uthors have documented that the first assumption is not always
orrect, although the second still remains uncertain. Further com-
licating this decision process is the realization that, at least for the
ypes of patients in this particular analysis, namely, those with
ritical LVOT obstruction, the single-ventricle approach perhaps
ffers the best outcomes among many variants of hypoplastic left
eart syndrome.
The authors performed an exhaustive analysis of multiple risk
actors for death for both UVR and BVR and then formed a
VR-SA tool that allowed them to reanalyze predicted survival for
hose whose repair was either concordant or discordant using
redictive formulas previously published. This model was further
efined and used to predict an optimal survival path for the patients
n the analysis.
Although there are multiple intriguing findings among these
ata, the authors found that discordant decision-making, namely,
ursuing BVR when UVR had a higher predicted survival or vice
ersa, costs lives. More important, a discordant BVR decision is
ore costly than a UVR one. The inference is that the marginal left
eart, for whatever reason, has little or no room to compensate and
ransfers all the risk up front. Equally important, although not
ddressed here, is the potential that many BVR survivors may also
ace repeated valve replacement procedures and pulmonary hyper-
ension in their later years. I have 2 questions for Dr. Hickey.
It seems from the analysis of their paper that a smaller mitral
alve annulus was a risk factor only for UVR. Others have re-
orted that the mitral valve size was strongly predictive of out-
ome for BVR. Could the authors provide some insight regarding
he influence of the mitral valve, either size or function, on survival
or BVR patients?
Second, do the authors believe that the more liberal use of
oss–Konno procedures, either with or without arch repair as
ember 2007
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CH
Deeded or even resection of EFE, might improve survival for
VR?
I thank Dr. Hickey for an excellent presentation.
Dr. Hickey. Thank you very much, Dr. Bove, for your com-
ents and your questions. The issue with the mitral valve annulus
s intriguing, because, as you point out, it was identified as a risk
actor for death following univentricular repair, which is clearly a
urprise. We explored this further, and our conclusions are as
ollows.
The mitral annular Z scores as a risk factor for univentricular
epair do not correlate with either mitral stenosis or mitral regur-
itation in this cohort. Therefore, this variable, although represent-
ng the mitral annulus, is not necessarily a functional variable. It is
morphological dimension that correlates strongly with overall
eft-sided structural hypoplasia. So it correlates with dimensions of
he LV outflow tract and the ventricular size and ventricular
ypoplasia. So it is in some ways misleading that it is the mitral
nnulus. It is, we feel, a variable representing the overall dimen-
ion and degree of left-sided hypoplasia.
So why is it not a risk factor for biventricular repair? Well, the
nswer to that is that we obviously looked at and explored the
otential for both functional regurgitation or stenosis as a risk
actor after biventricular repair, including mitral morphology and
imensions. All of these variables were overshadowed in our
tatistical analysis by more robust variables—namely, the degree
f LV dysfunction—and particularly the severity of endocardial s
The Journal of Thoracicbroelastosis or thickening, which is an extremely strong predictor
f poor prognosis after biventricular repair. So although we don’t
eny that mitral valve variables have been reported as important in
ther series, here they have been overshadowed by other functional
nd morphologic left-sided variables.
In regard to your second question and the use of neonatal
oss–Konno procedures, we have been looking at the index pro-
edure as the intention to treat. Invariably in our series this was
ither through balloon aortic valvotomy or surgical valvotomy,
ith only a minority of more complex repairs (namely, 2 Yasui
nd 5 index Ross–Konno procedures). A number of other Ross–
onno procedures were undertaken subsequently as repeat
nterventions—in fact, a total of 30. Overall outcome for these was
6% survival at 5 years. Now, of course there are reports of further
mproved survival with Ross–Konno procedures, and this may
ranslate into a further bias towards management. However, at the
ame time as that survival will have improved with Ross–Konno
rocedures, survival also will have improved over the intervening
ecade with staged Norwood palliation, for example. So the only
ay of actually determining whether index Ross–Konno results in
mproved BVR survival is to undertake a contemporary investiga-
ion in which we enroll a higher proportion of Ross–Konno pro-
edures and complex repairs. In fact, that is an investigation that
he CHSS are looking at now with our latest LV outflow tract
eries.
and Cardiovascular Surgery ● Volume 134, Number 6 1437
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DFigure E1. Algorithm indicating the profile of neonate
between 1994 and 2001. The present study analyzed the
age 30 days) indicating intended univentricular or biv
tricular repair; BVR, biventricular repair; LVOT, left ve
Society.s with critical LVOT obstruction enrolled with the CHSS
362 neonates who underwent an index procedure (within
entricular repair. HTX, Heart transplantation; UVR, univen-
ntricular outflow tract; CHSS, Congenital Heart Surgeons’437.e1 The Journal of Thoracic and Cardiovascular Surgery ● December 2007
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DABLE E1. Selected patient characteristics (preintervention) used for multivariate analysis*
Biventricular Univentricular
n Dead m Value n Dead m Value
ead 139 39 0 39 223 84 0 84
eneral
ale 139 31 0 118 223 53 0 156
SA (m2) 139 — 0 .225 (.12–.33) 223 — 0 .220 (.16–.30)
eight (kg) 139 — 0 3.4 (1.3–6.1) 223 — 0 3.2 (1.9–5.4)
ge at intervention (d) 139 — 0 6.7 (0–30) 223 — 0 6.9 (0–29)
rocedural details
rocedure type 139 — 0 — 223 — 0 —
Autograft AVR 3 5 — — — —
Balloon aortic valvotomy 23 105 — — — —
Surgical aortic valvotomy 12 27 — — — —
Yasui procedure 1 2 — — — —
Norwood palliation — — — — 223 84 0 223
ssociated lesions
dentifiable genetic syndrome 139 0 0 1 223 3 0 7
oncardiovascular abnormality 139 3 0 6 223 7 0 14
ssociated cardiovascular abnormality 139 2 0 6 223 6 0 14
oarctation 129 7 10 17 191 31 32 72
eft SVC 139 1 0 1 223 11 0 27
eptum/endocardium
SD 108 10 31 24 171 24 52 69
SD 117 4 22 8 183 20 40 45
SD, large 116 2 23 4 172 8 51 13
FE, grade 96 43 149 74
0 7 48 23 63
1 11 39 21 59
2 3 6 7 24
3 3 3 1 3
V function/size
rade of LV dysfunction 124 15 146 77
Normal 6 53 10 32
Mild 4 11 14 36
Moderate 9 23 16 38
Severe 15 37 13 40
jection fraction (%) 50 — 89 47 (4–90) 11 — 212 40 (16–76)
ength of dominant ventricle (cm) 88 — 51 3.2 (2.4–4.4) 144 — 79 29 (18–41)
V-forming apex 99 40 19 160 63 142
hodes score 86 — 53 .4 (4.2–1.9) 131 — 92 2.8 (5.5–.3)
itral valve
R, moderate or severe 122 9 17 20 216 57 49 7
S, moderate or severe 115 18 24 35 200 55 23 147
-score MV annulus 108 — 31 1.4 (7.0–5.1) 187 — 36 5.5 (14.4–.47)
ricuspid valve
R, moderate or severe 93 5 46 8 209 8 65 14
-score of TV annulus 77 — 62 2.0 (6.5–1.8) 137 — 86 1.2 (11.8–3.7)
ubaortic region/LVOT
ub-AoV stenosis 101 4 38 7 137 10 86 28
ub-AoV diameter (cm) 91 — 48 .54 (.26–.87) 140 — 83 .38 (.18–.66)
oV annulus (cm) 130 — 9 .59 (.37–.85) 202 — 21 .43 (.15–1.0)
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DABLE E1. Continued
Biventricular Univentricular
n Dead m Value n Dead m Value
-score of AoV annulus 130 — 9 3.9 (10.9–1.4) 202 — 21 8.6 (24.5–3.6)
oV sinus diameter (cm) 91 — 48 .79 (.4–1.1) 146 — 77 .63 (.2–1.1)
-score at sinuses 91 — 48 2.9 (11.7–1.7) 146 — 77 5.8 (22.8–.22)
inotubular junction diameter (cm) 87 — 52 .72 (.4–1.2) 132 — 91 .52 (.2–1.0)
-score at sinotubular junction 87 — 52 0.6 (5.0–5.2) 132 — 91 4.2 (17.3–2.5)
scending aorta (cm) 108 — 31 .83 (.34–1.4) 208 — 15 .53 (.15–1.1)
eak LVOT gradient 110 — 29 67 (4–174) 85 — 138 26 (0–87)
ean LVOT gradient 72 — 67 41 (1–102) 51 — 172 14 (1–49)
Institutional medical records were obtained that described patient demographics, pre-intervention echocardiography and angiography, procedural details,
nd autopsy reports where appropriate. Echocardiography recordings were requested and those obtained (n  214) were examined independently by a
linded reviewer. Dimensional variables were standardized and expressed as z-scores on the basis of published normative data if available, or otherwise
ndexed to either body surface area or height. For risk-hazard analysis, missing values were imputed with the mean for that variable and a general missing
alue indicator created. This general missing value indicator was subsequently tested as a parameter in the regression analysis to refute the notion that
atients with missing data may be different in terms of characteristics or risk from those in whom the data are not missing. Variables with excessive (75%)
issing values or associated with fewer than 5 deaths were suppressed during multivariate analysis to avoid the risk of over-determination. AVR, Aortic
alve replacement; BSA, body surface area; SVC, superior vena cava; ASD, atrial septal defect; VSD, ventricular septal defect; EFE, endocardial
broelastosis; LV, left ventricle; RV, right ventricle; MV, mitral valve; MR, mitral regurgitation; MS, mitral stenosis; TR, tricuspid regurgitation; TV, tricuspid
alve; AoV, aortic valve; LVOT, left ventricular outflow tract; n, number of nonmissing values; m, number of missing values.Figure E2. Subsequent procedures and mortality for patients who had an initial procedure indicating an intended
univentricular management strategy. Bold entries represent “crossovers” (n  7) to an alternative management
strategy (BVR or transplantation) during the follow-up period. UVR, Univentricular repair; CPC, cavopulmonary
connection; HTX, heart transplantation.
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CH
DFigure E3. Subsequent procedures and mortality for neonates (n  105) whose initial procedure was a balloon
aortic valvotomy (BAV). Italicized entries represent “crossovers” (n  7) to an alternative management strategy
(UVR or transplantation) during the follow-up period. AVR, Aortic valve replacement; SAV, surgical aortic
valvuloplasty; HTX, heart transplantation; CPC, cavopulmonary connection; SVALV, open surgical valvotomy;
BVALV, balloon aortic valvotomy.Figure E4. Subsequent procedures and mortality for patients who had an initial open surgical procedure indicating
an intended BVR strategy. Bold entries represent “crossovers” (n  5) to the opposite management strategy (BVR)
during the follow-up period. BAV, Balloon aortic valvotomy; AVR, aortic valve replacement (Ross–Konno proce-
dure); SAV, surgical aortic valvuloplasty; SVALV, open surgical valvotomy.
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Digure E5. Unadjusted time-related survival plots for the study
opulation stratified by intended management strategy. Solid line
epresents BVR (n  139, 39 deaths). Dashed line represents UVR
n  223, 84 deaths). Circles represent actuarial Kaplan–Meier
stimates at events (deaths). Lines represent parametric contin-
ous point estimates. The hazard domain for both BVR and UVR
urvival was only early, with no appreciable constant or late
hases. Eighty-four percent of deaths had occurred within 1 year
nd 94% within 3 years. The difference in unadjusted survival
etween UVR and BVR did not reach statistical significance (P 
07). Error bars enclose 70% confidence intervals. BVR, Biven-
ricular repair; UVR, univentricular repair.437.e5 The Journal of Thoracic and Cardiovascular Surgery ● December 2007
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CH
DFigure E6. Risk-adjusted percentage survival after UVR (n  223) stratified by (a) the presence of moderate or
severe tricuspid regurgitation, (b) the presence of a large ventricular septal defect (VSD), (c) smaller mitral valve
annular z-score, or (d) smaller indexed length of the dominant ventricle. For each stratified plot the remaining 3
variables are set at their mean value, and for the indexed length of the dominant ventricle stratifications are shown
for values based on mean heights and weights. Lines represent the parametric determination of continuous point
estimates of survival. UVR, Univentricular repair.The Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 6 1437.e6
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DFigure E7. Risk-adjusted percentage survival after BVR (n  139) stratified by (a) smallest indexed minimum
diameter of the left ventricular outflow tract, (b) the presence of left ventricular dysfunction, (c) grade of
endocardial fibroelastosis, or (d) indexed diameter of the transverse aortic arch immediately proximal to the left
subclavian artery. For each stratified plot the remaining 3 variables are set at their mean value, and for indexed
left ventricular outflow tract and arch diameters, stratifications are shown for values based on mean heights and
weights. Lines represent the parametric determination of continuous point estimates of survival. BVR, Biventricular
repair.437.e7 The Journal of Thoracic and Cardiovascular Surgery ● December 2007
